Yoo Roh-Eul, Kim Ji-Hoon, Hwang Inpyeong, Kang Koung Mi, Yun Tae Jin, Choi Seung Hong, Sohn Chul-Ho, Park Sun-Won
Department of Radiology, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea.
Department of Radiology, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 03080, Korea.
Cancers (Basel). 2020 May 8;12(5):1190. doi: 10.3390/cancers12051190.
Diagnostic accuracy of US in the evaluation of lymph node (LN) metastasis for thyroid cancer patients is limited. We investigated the value of CT added to US for characterizing LNs in preoperative thyroid cancer patients by node-by-node correlation. A total of 225 primary thyroid cancer patients who underwent LN biopsy were included. Based on node-by-node correlation, 274 LNs were classified into probably benign, indeterminate, and suspicious categories on US, CT, and combined US/CT. Malignancy risks were calculated for each category and were compared between US/CT concordant and discordant cases. On US, CT, and combined US/CT, malignancy risks were 1.7%, 8.7%, and 0% in the probably benign category, 22.4%, 5.9%, and 8.0% in the indeterminate category, and 77.2%, 82.0%, and 75.6% in the suspicious category, respectively. Malignancy risk of the concordant suspicious category was higher than that of the discordant suspicious category (84.7% vs. 43.2%, < 0.001). The addition of CT helped correctly detect additional metastasis in 16.4% of the US indeterminate LNs and in 1.7% of the US probably benign LNs. CT may complement US for LN characterization in thyroid cancer patients by suggesting the diagnostic confidence level for the suspicious category and helping correctly detect metastasis in US indeterminate LNs.
超声在评估甲状腺癌患者淋巴结(LN)转移方面的诊断准确性有限。我们通过逐个淋巴结相关性研究了CT联合超声在术前甲状腺癌患者淋巴结特征分析中的价值。共纳入225例行淋巴结活检的原发性甲状腺癌患者。基于逐个淋巴结相关性,274个淋巴结在超声、CT及联合超声/CT检查中被分为可能良性、不确定和可疑三类。计算每类的恶性风险,并在超声/CT结果一致和不一致的病例之间进行比较。在超声、CT及联合超声/CT检查中,可能良性类别的恶性风险分别为1.7%、8.7%和0%,不确定类别的恶性风险分别为22.4%、5.9%和8.0%,可疑类别的恶性风险分别为77.2%、82.0%和75.6%。一致的可疑类别的恶性风险高于不一致的可疑类别(84.7%对43.2%,<0.001)。CT的加入有助于正确检测出16.4%的超声不确定淋巴结及1.7%的超声可能良性淋巴结中的额外转移。CT可通过提示可疑类别的诊断置信度并帮助正确检测超声不确定淋巴结中的转移,来补充超声对甲状腺癌患者淋巴结的特征分析。